Italia markets closed

Bristol-Myers Squibb Company (0R1F.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
72,70+0,20 (+0,28%)
Alla chiusura: 06:03PM GMT
Schermo intero
Chiusura precedente72,50
Aperto73,28
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno72,71 - 72,83
Intervallo di 52 settimane57,97 - 81,40
Volume470
Media Volume354.443
Capitalizzazione1,2B
Beta (5 anni mensile)0,37
Rapporto PE (ttm)0,26
EPS (ttm)2,82
Prossima data utili25 apr 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri